Information  X 
Enter a valid email address

GlaxoSmithKline PLC (GSK)

  Print      Mail a friend       Annual reports

Friday 11 May, 2012

GlaxoSmithKline PLC

Director/PDMR Shareholding

RNS Number : 2041D
GlaxoSmithKline PLC
11 May 2012
 



 

 

 

 

 

 

 

 Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

 

 

Following a revaluation of the cash element of the notional investment held within the US Retirement Savings Plan (The Plan), which is notionally held in GSK American Depositary Shares (ADSs), the Administrators of the Plan notified GlaxoSmithKline plc and the under-mentioned Persons on 11 May 2012 of an increase in the notional allocation of ADSs on 10 May 2012 at a price of $45.50 per ADS:-

 

 

Director/PDMR

 

 

 

Number of ADSs

 

Connected Person

 

Number of ADSs

 

Dr M M Slaoui

 

 

11

 

Dr K Slaoui

 

9

Mr W C Louv

 

16

-

-

Dr D Pulman

 

29

-

-

Mr E J Gray

 

21

-

-

Mrs D P Connelly

 

1

-

-

 

 


 

This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a) and (c).

 

 

V A Whyte

Company Secretary

 

11 May 2012

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSZFLFFLEFLBBX

a d v e r t i s e m e n t